Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Numinus Wellness Inc NUMIF


Primary Symbol: T.NUMI

Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training segment is engaged in education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network segment includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. Corporate segment includes finance, marketing, information technology, legal, and human resources.


TSX:NUMI - Post by User

Post by Alexandchoyon Jun 17, 2021 6:39pm
315 Views
Post# 33408870

What ATAI IPO means for shroom sector + my pick

What ATAI IPO means for shroom sector + my pick

With ATAI IPO incoming, the shroom sector has eyes on it again. I’m expecting to see an uptick in volume across the sector for the legit shroom companies. 

 

Identifying which are legit can be challenging but I think I found one upcoming IPO that will stand out from the rest - Levitee Labs = $LVT.

 

Before I say anything else, they are profitable. Through accretive M&A they have established a portfolio of cash flow assets with 2021 rev = $16.6M and EBITDA $3M.

 

This may be the worlds first psychedelic company with significant rev and cash flow.

 

On top of that, their cap structure is extremely tight with only 75M shares out and more than half owned by management and insiders that are locked up with selling restrictions. 

 

Current valuation estimated at $37M mc ... I don’t see it staying that low for long. 

 

If you were ever going to invest in psychedelics, this is the one.

 

https://twitter.com/shroomstreet/status/1389259375651475461?s=21

 

<< Previous
Bullboard Posts
Next >>